top of page
PRECISION ENGINEERED.
MULTIFUNCTIONAL MEDICINES.
Orchestrating the next movement in biotechnology through AI-driven protein engineering, synthetic biology, and a strategic hub-and-spoke model
MUXBODIES™
Complex diseases demand smarter biologics. Protuoso Bio engineers MUXBODIES™ - multifunctional protein architectures that integrate precision design with scalable innovation - for an expanding therapeutic portfolio.
Scalable Multi-Asset Portfolio
Protuoso Bio's hub-and-spoke strategy leverages a centralized protein-engineering hub to enable focused development of multiple assets. This structure supports parallel innovation, disciplined resource allocation, and efficient portfolio expansion. By combining strategic oversight with asset-level execution, we drive scalable growth while preserving capital efficiency.
Orchestrated Protein Multifunctionality
Protuoso Bio engineers synergistic protein architectures for enhanced efficacy and safety in diseases with complex biology. By designing multiple modalities and mechanisms into a single molecular architecture, we aim to improve upon suboptimal therapies while preserving precision and control.
Bioengineering with Purpose
Protuoso Bio combines advanced AI-driven protein engineering, computaional protein design, and synthetic biology to design differentiated, next-generation biologics for high-impact therapeutics. Our platform enables precise control of complex biology through modular and multifunctional architectures.
MUXBODIES
Complex diseases demand smarter biologics. Protuoso engineers MUXBODIES™ which are multifunctional protein architectures that integrate precision design with scalable innovation across a growing therapeutic portfolio.
Scalable Multi-Asset Portfolio
Avidity through Multifunctionality
Bioengineering with Purpose
Asset Class 1
Advanced Cardiometabolic Biologics
Other Assets
Multiple Assets in Stealth
Asset Class 2
Armored Immune Cell Engagers
Therapeutic-Agnostic Hub-and-Spoke Model
Protuoso Bio leverages its MUXBODIES™ to target complex diseases with high unmet need and strong commercial validation with differentiated efficacy.
Asset Class 1
Advanced Cardiometabolic Proteins
Asset Class 2
Armoured Immune Cell Engagers
Other Assets
Multiple Assets in Stealth
Therapeutic-Agnostic Hub-and-Spoke Model
Protuoso Bio leverages its MUXBODIES™ to target complex diseases with high unmet need and strong commercial validation with unprecedented efficacy.
LEADERSHIP TEAM
A world-class performance requires a world-class ensemble. Our leadership team is comprised of Protein Virtuosos who bring decades of experience from top-tier pharma, biotech, and research institutions with proven success across R&D, fundraising, and strategic transactions.
Willie Xiang
Co-Founder, President and
Chief Operating Officer
Tim Lu, MD, PhD
Co-Founder, Chairman and
Chief Scientist
Jim McGuire, PhD
Asset Class 1
Chief Scientific Officer
Erik Heegaard, MD, PhD
Asset Class 1
Chief Medical Officer
Rick Austin, PhD
Asset Class 2
Chief Scientific Officer
Joel Edwards
Asset Class 2
Chief Strategy Officer
Mike Lai, MD
Protuoso Bio Hub
Senior Advisor
_edited.png)
Laura Brege
Protuoso Bio Hub
Senior Advisor
Who We Are, Where We Came From, and Where We’re Headed
CONTACT US
1030 Brittan Avenue
San Carlos, CA 94070
CONTACT US
1030 Brittan Avenue
San Carlos, CA 94070
FOLLOW US
bottom of page